Optimal Dose of Plasmid Vascular Endothelial Growth Factor for Enhancement of Angiogenesis in the Rat Brain Ischemia Model
スポンサーリンク
概要
- 論文の詳細を見る
Vascular endothelial growth factor (VEGF) administration has recently been assessed as a therapeutic strategy for ischemic diseases including brain ischemia because of its angiogenic effect. However, VEGF also causes detrimental adverse effects by increasing vascular permeability. This study examined whether plasmid human VEGF (phVEGF) administration induced angiogenic effects in the rat brain ischemia model caused by permanent ligation of both common carotid arteries, and investigated the occurrence of adverse effects. Administration of various doses (0-200 μg) of phVEGF in the temporal muscle was followed by encephalo-myo-synangiosis. Thirty days after treatment, the numbers and areas of capillaries per field in the extracted brains were analyzed with the National Institutes of Health Image software program. The maximal angiogenic effect occurred with a 100 μg dose of phVEGF in the numbers and areas of capillaries in the VEGF-treated brains. Histological examination showed no apparent adverse effects in the brain parenchyma even at the highest administration dose (200 μg) of phVEGF. The maximal angiogenic effect at the optimal dose of phVEGF can be considered under the threshold to cause serious adverse effects in the rat brain.
論文 | ランダム
- 信認関係に基づく個人情報のセキュリティ
- 新たな幼児教育の創出に向けて、幼稚園教育の成果を問う試み ―幼稚園の3歳児保育の内容に着目して―
- 謝雪紅と台湾民主自治同盟 : 中台関係と評価の変遷
- 養殖魚の飼料開発と宇宙時代の水産養殖 (特集 ニッポンの養殖)
- K-2307 磁気駆動Fe-Pd形状記憶合金の機能向上のための界面制御(S13-2 多機能・複合機能化への材料協調設計(2))(S13 多機能・複合機能化への材料協調設計)